Camber Launches Nitazoxanide Tablets
Giardia and Cryptosporidium infections affect an estimated 2 million people annually in the United States, according to estimates from the CDC. Camber recently launched Nitazoxanide Tablets [NYE-ta-ZOX-a-nide], generic to Alinia®, helping expand access to treatment for these parasitic infections.
Nitazoxanide Tablets are antiprotozoal indicated for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum.
Nitazoxanide Tablets are available in 6 count bottles of 500 mg strengths.
Click here to learn more about Nitazoxanide Tablets.
Recent articles
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
- New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards






